tradingkey.logo

ASP Isotopes Inc

ASPI
View Detailed Chart
9.150USD
-0.980-9.67%
Close 11/03, 16:00ETQuotes delayed by 15 min
767.73MMarket Cap
LossP/E TTM

ASP Isotopes Inc

9.150
-0.980-9.67%
Intraday
1m
30m
1h
D
W
M
D

Today

-9.67%

5 Days

-9.32%

1 Month

-2.03%

6 Months

+56.95%

Year to Date

+101.99%

1 Year

+17.46%

View Detailed Chart

TradingKey Stock Score of ASP Isotopes Inc

Currency: USD Updated: 2025-11-03

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

ASP Isotopes Inc's Score

Industry at a Glance

Industry Ranking
102 / 159
Overall Ranking
265 / 4617
Industry
Pharmaceuticals

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 1 analysts
Buy
Current Rating
11.000
Target Price
+8.59%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

ASP Isotopes Inc Highlights

StrengthsRisks
ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
Growing
The company is in a growing phase, with the latest annual income totaling USD 4.14M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 4.14M.
Fairly Valued
The company’s latest PE is -6.52, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 45.23M shares, increasing 11.78% quarter-over-quarter.
Held by Paul Tudor Jones
Star Investor Paul Tudor Jones holds 335.00K shares of this stock.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

ASP Isotopes Inc Info

ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
Ticker SymbolASPI
CompanyASP Isotopes Inc
CEOMr. Paul Elliot Mann
Websitehttps://aspisotopes.com/
KeyAI